Baricitinib, a drug against rheumatoid arthritis, could potentially be repurposed to treat patients with COVID-19, according to an international study conducted by among others researchers at Karolinska Institutet. Baricitinib is a once-daily oral drug used for treatment of adult patients with moAlready a subscriber Login You have read all your…